These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 10391608

  • 1. The treatment of heparin resistance with Antithrombin III in cardiac surgery.
    Kanbak M.
    Can J Anaesth; 1999 Jun; 46(6):581-5. PubMed ID: 10391608
    [Abstract] [Full Text] [Related]

  • 2. [The effect of antithrombin iii concentrations during cardiopulmonary surgery].
    Sonzogni V, Bellavita P, Carrara B, Cossolini M, Ferri F, Fabretti F, Mamprin F, Pelliccioli I.
    Minerva Anestesiol; 2000 Jun; 66(1-2):17-23. PubMed ID: 10736978
    [Abstract] [Full Text] [Related]

  • 3. Monitoring and management of anticoagulation in children requiring extracorporeal circulation.
    Malviya S.
    Semin Thromb Hemost; 1997 Jun; 23(6):563-7. PubMed ID: 9469631
    [Abstract] [Full Text] [Related]

  • 4. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B, Sutlic Z.
    Heart Surg Forum; 2002 Jun; 5(2):182-6. PubMed ID: 12125670
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W, Deyo DJ, Brunston RL, Vertrees RA, Grochoske TL, Zwischenberger JB.
    ASAIO J; 1997 Jun; 43(5):M825-30. PubMed ID: 9360162
    [Abstract] [Full Text] [Related]

  • 6. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ, Joist JH.
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [Abstract] [Full Text] [Related]

  • 7. Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity and coagulation during nitroglycerine infusion in coronary artery bypass surgery.
    Kanbak M, Oc B, Salman MA, Ocal T, Oc M.
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):593-9. PubMed ID: 21799398
    [Abstract] [Full Text] [Related]

  • 8. Relationships between antithrombin activity, anticoagulant efficacy of heparin therapy and perioperative variables in patients undergoing cardiac surgery requiring cardiopulmonary bypass.
    Muedra V, Bonanad S, Gómez M, Villalonga V, Sánchez F, Llopis JE.
    Perfusion; 2011 Nov; 26(6):487-95. PubMed ID: 21665912
    [Abstract] [Full Text] [Related]

  • 9. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
    Avidan MS, Levy JH, van Aken H, Feneck RO, Latimer RD, Ott E, Martin E, Birnbaum DE, Bonfiglio LJ, Kajdasz DK, Despotis GJ.
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
    [Abstract] [Full Text] [Related]

  • 10. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant?
    Brister SJ, Ofosu FA, Buchanan MR.
    Thromb Haemost; 1993 Aug 02; 70(2):259-62. PubMed ID: 8236131
    [Abstract] [Full Text] [Related]

  • 11. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M, Velik-Salchner C, Stalzer B, Margreiter J, Klingler A, Streif W, Fries D, Innerhofer P.
    Anesth Analg; 2009 Mar 02; 108(3):743-50. PubMed ID: 19224778
    [Abstract] [Full Text] [Related]

  • 12. [Heparin resistance associated with elevated factor VIII].
    Kumano N, Ikeda S, Arimori Y, Ono T, Saeki S.
    Masui; 2008 Apr 02; 57(4):471-3. PubMed ID: 18416208
    [Abstract] [Full Text] [Related]

  • 13. Safety issues in heparin and protamine administration for extracorporeal circulation.
    Jobes DR.
    J Cardiothorac Vasc Anesth; 1998 Apr 02; 12(2 Suppl 1):17-20. PubMed ID: 9583571
    [Abstract] [Full Text] [Related]

  • 14. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
    Okita Y, Takamoto S, Ando M, Morota T, Yamaki F, Matsukawa R, Kawashima Y.
    Circulation; 1997 Nov 04; 96(9 Suppl):II-376-81. PubMed ID: 9386127
    [Abstract] [Full Text] [Related]

  • 15. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB, Veerhoek D, van den Brom CE, van Barneveld LJ, Boer C.
    J Cardiothorac Vasc Anesth; 2014 Apr 04; 28(2):235-41. PubMed ID: 24342152
    [Abstract] [Full Text] [Related]

  • 16. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT.
    Despotis GJ, Joist JH, Hogue CW, Alsoufiev A, Joiner-Maier D, Santoro SA, Spitznagel E, Weitz JI, Goodnough LT.
    Thromb Haemost; 1996 Dec 04; 76(6):902-8. PubMed ID: 8972009
    [Abstract] [Full Text] [Related]

  • 17. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA, Culliford AT, Colvin SB, Thomas SJ, Lackner H, Spencer FC.
    J Thorac Cardiovasc Surg; 1983 Feb 04; 85(2):174-85. PubMed ID: 6823136
    [Abstract] [Full Text] [Related]

  • 18. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT, Monn A, Tavakoli R, Genoni M, Klaghofer R, Furrer L, Honegger H, Hofer CK.
    Eur J Cardiothorac Surg; 2006 Aug 04; 30(2):278-84. PubMed ID: 16828293
    [Abstract] [Full Text] [Related]

  • 19. Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary bypass.
    Teoh KH, Young E, Bradley CA, Hirsh J.
    Circulation; 1993 Nov 04; 88(5 Pt 2):II420-5. PubMed ID: 8222188
    [Abstract] [Full Text] [Related]

  • 20. Changing systems for measuring activated clotting times: impact on the clinical practice of heparin anticoagulation during cardiac surgery.
    Patteril M, Stafford-Smith M, Toffaletti JG, Bute BP, Milano CA, Welsby IJ.
    Clin Chim Acta; 2005 Jun 04; 356(1-2):218-24. PubMed ID: 15936321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.